Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Tolerability of More than Six Days of Tedizolid Treatment.
Mensa Vendrell M, Tasias Pitarch M, Salavert Lletí M, Calabuig Muñoz E, Morata Ruiz L, Castells Lao G, López Suñé E, Mensa Pueyo J, Oltra Sempere MR, Pedro-Botet Montoya ML, Isernia V, Reynaga Sosa EA, Moreno Nuñez L, Pasquau Liaño J, Sequera Arquelladas S, Yuste Ara JR, Soriano Viladomiu A. Mensa Vendrell M, et al. Among authors: isernia v. Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00356-20. doi: 10.1128/AAC.00356-20. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32312777 Free PMC article.
Approach for initial treatment of skin and soft tissue infection.
González del Castillo J, Isernia V, Candel FJ, Martín-Sánchez FJ. González del Castillo J, et al. Among authors: isernia v. Clin Infect Dis. 2015 Jan 1;60(1):169-71. doi: 10.1093/cid/ciu776. Epub 2014 Oct 8. Clin Infect Dis. 2015. PMID: 25296664 No abstract available.
Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection.
Bachelard A, Isernia V, Vallois D, Le Gac S, Chalal L, Landman R, Damond F, Descamps D, Yazdanpanah Y, Peytavin G, Ghosn J. Bachelard A, et al. Among authors: isernia v. J Antimicrob Chemother. 2021 Aug 12;76(9):2484-2485. doi: 10.1093/jac/dkab192. J Antimicrob Chemother. 2021. PMID: 34109414 No abstract available.
Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1.
Bachelard A, Sautereau A, Digumber M, Isernia V, Phung B, Lehur AC, Gac SL, Landman R, Yazdanpanah Y, Ghosn J. Bachelard A, et al. Among authors: isernia v. Int J Infect Dis. 2022 Sep;122:152-154. doi: 10.1016/j.ijid.2022.05.055. Epub 2022 May 29. Int J Infect Dis. 2022. PMID: 35649498 Free PMC article.
Case report study of the first five COVID-19 patients treated with remdesivir in France.
Dubert M, Visseaux B, Isernia V, Bouadma L, Deconinck L, Patrier J, Wicky PH, Le Pluart D, Kramer L, Rioux C, Le Hingrat Q, Houhou-Fidouh N, Yazdanpanah Y, Ghosn J, Lescure FX. Dubert M, et al. Among authors: isernia v. Int J Infect Dis. 2020 Sep;98:290-293. doi: 10.1016/j.ijid.2020.06.093. Epub 2020 Jun 30. Int J Infect Dis. 2020. PMID: 32619764 Free PMC article.
21 results